McLaughlin Vallerie 4

What Happened
Vallerie McLaughlin, a director of Clene Inc., was granted an option to acquire 3,030 shares of common stock on February 19, 2026. The Form 4 reports this as an award (derivative acquisition) with an acquisition price of $0; the option has an exercise price of $4.73 per share under the Clene Inc. Amended 2020 Stock Plan and vests immediately upon grant (Footnote F1). Exercising all options would require roughly $14,331.90 (3,030 × $4.73).

Key Details

• Transaction date: 2026-02-19; Form 4 filed: 2026-02-20 (timely filing).
• Transaction type/code: Award/Grant (derivative acquisition, code A).
• Quantity: 3,030 option shares; exercise price $4.73 per share.
• Acquisition price reported on Form 4: $0 (award).
• Vesting: Options vest immediately upon grant (per F1).
• Plan: Granted under Clene Inc. Amended 2020 Stock Plan.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context
This filing records a stock option grant (not an open‑market purchase or a sale). The award gives the director the right to buy shares at $4.73 each; value is only realized if and when the options are exercised and/or shares are sold. Director option grants are common forms of compensation and do not, by themselves, indicate a buy/sell decision—they're different from cash purchases by insiders.